Vilanterol
Vilanterol is an inhaled ultra-long-acting beta2-adrenergic agonist (LABA). It works by relaxing the smooth muscle of the airways, leading to bronchodilation and improved airflow. Because of safety concerns with LABA monotherapy, vilanterol is only available in fixed-dose combination products with other respiratory medications, such as fluticasone furoate (an inhaled corticosteroid) or umeclidinium (a long-acting muscarinic antagonist).
Dosage by Body Weight
Vilanterol is administered strictly via oral inhalation once daily at the same time each day. It is not a rescue medication and must not be used to treat acute bronchospasm or asthma attacks. Dosages are determined by the specific combination product prescribed.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric patients.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric patients.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric patients.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric patients.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric patients.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric patients. |
| 5-7 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric patients. |
| 8-10 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric patients. |
| 11-15 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric patients. |
| 16-20 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric patients. |
Formulation
Purpose
Long-acting beta2-adrenergic agonist (LABA) used for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with COPD (including chronic bronchitis and emphysema) and asthma, always in combination with an inhaled corticosteroid or long-acting muscarinic antagonist.
Generic Name
VilanterolBranded Drug Names
Vilanterol is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.